Nanodrug Delivery Strategies to Signaling Pathways in Alopecia

被引:5
作者
Wu, Xiaochuan [1 ,2 ]
Du, Yong-zhong [1 ,2 ]
机构
[1] Zhejiang Univ, Jinhua Inst, Jinhua 321299, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Pharmaceut, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China
关键词
hair regrowth; alopecia; signaling pathway; drug delivery; nanotechnology; DERMAL PAPILLA CELLS; MESENCHYMAL STEM-CELLS; PROMOTES HAIR-GROWTH; ANDROGENETIC ALOPECIA; LIPID NANOPARTICLES; IN-VITRO; WNT/BETA-CATENIN; CYCLOSPORINE-A; DOUBLE-BLIND; CROSS-TALK;
D O I
10.1021/acs.molpharmaceut.3c00620
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Over 50% of the global population suffers from hair loss. The mixed results in the treatment of hair loss reveal the limitations of conventional commercial topical drugs. One the one hand, the definite pathogenesis of hair loss is still an enigma. On the other hand, targeted drug carriers ensure the drug therapeutic effect and low side effects. This review highlights the organization and overview of nine crucial signaling pathways associated with hair loss, as well as the development of nanobased topical delivery systems loading the clinical drugs, which will fuel emerging hair loss treatment strategies.
引用
收藏
页码:5396 / 5415
页数:20
相关论文
共 239 条
[1]   Minoxidil Skin Delivery from Nanoemulsion Formulations Containing Eucalyptol or Oleic Acid: Enhanced Diffusivity and Follicular Targeting [J].
Abd, Eman ;
Benson, Heather A. E. ;
Roberts, Michael S. ;
Grice, Jeffrey E. .
PHARMACEUTICS, 2018, 10 (01)
[2]  
Abdel-Moiti AM, 2023, The Egyptian Journal of Hospital Medicine, V90, P1284, DOI [10.21608/ejhm.2023.282023, 10.21608/ejhm.2023.282023]
[3]   Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy [J].
Abdel-Wahab, Ali F. ;
Mahmoud, Waheed ;
Al-Harizy, Randa M. .
PHARMACOLOGICAL RESEARCH, 2019, 150
[4]   Novel iron oxide nanocarriers loading finasteride or dutasteride: Enhanced skin penetration for topical treatment of alopecia [J].
Afiune, Luana A. F. ;
Ushirobira, Camila Y. ;
Barbosa, Debora P. P. ;
Souza, Paulo E. N. de ;
Leles, Maria I. G. ;
Cunha-Filho, Marcilio ;
Gelfuso, Guilherme M. ;
Soler, Maria A. G. ;
Gratieri, Tais .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 587
[5]   Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach [J].
Ahmed, Osama A. A. ;
Rizq, Waleed Y. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 :2259-2265
[6]   Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation [J].
Ahmed, Tarek A. ;
Al-Abd, Ahmed M. .
DRUG DELIVERY, 2018, 25 (01) :555-563
[7]   Novel drug delivery approaches for the management of hair loss [J].
Alsalhi, Waleed ;
Alalola, Ammar ;
Randolph, Michael ;
Gwillim, Eran ;
Tosti, Antonella .
EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (03) :287-295
[8]   Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia [J].
Anudeep, Talagavadi Channaiah ;
Jeyaraman, Madhan ;
Muthu, Sathish ;
Rajendran, Ramya Lakshmi ;
Gangadaran, Prakash ;
Mishra, Prabhu Chandra ;
Sharma, Shilpa ;
Jha, Saurabh Kumar ;
Ahn, Byeong-Cheol .
PHARMACEUTICS, 2022, 14 (03)
[9]  
Arif T, 2017, CURR CLIN PHARMACOL, V12, P31, DOI 10.2174/1574884712666170310111125
[10]   Androgens in women Hormone-modulating therapies for skin disease [J].
Azarchi, Sarah ;
Bienenfeld, Amanda ;
Lo Sicco, Kristen ;
Marchbein, Shari ;
Shapiro, Jerry ;
Nagler, Arielle R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (06) :1509-1521